List of redirects

Jump to navigation Jump to search

Showing below up to 50 results in range #20,901 to #20,950.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. Ezetimibe labels and packages → Ezetimibe
  2. Ezetimibe nonclinical toxicology → Ezetimibe
  3. Ezetimibe overdosage → Ezetimibe
  4. Ezetimibe patient counseling information → Ezetimibe
  5. Ezetimibe use in specific populations → Ezetimibe
  6. Ezetimibe warnings and precautions → Ezetimibe
  7. Ezide → Hydrochlorothiazide
  8. F-actin → Actin
  9. F-center → F-Center
  10. F.A. Davis Company → F. A. Davis Company
  11. F.I.R.E. → Efficacy Of Fx06 In The Prevention Of Myocardial Reperfusion Injury Trial
  12. F.I.R.E. Study Misses Primary Endpoint → Special:Badtitle/NS100:F.I.R.E. Study Misses Primary Endpoint
  13. F.W. Aston → Francis William Aston
  14. F. necrophorum → Fusobacterium necrophorum
  15. F2R → Coagulation factor II receptor
  16. F508del → ΔF508
  17. F508del-CFTR → ΔF508
  18. FA → Fanconi anemia
  19. FAAH → Fatty acid amide hydrolase
  20. FAAT → Fatty Acid Antiarrhythmia Trial
  21. FACIT → Folate After Coronary Intervention Trial
  22. FACS → Fellow of the American College of Surgeons
  23. FACSM → Fellow of the American College of Sports Medicine
  24. FACT → Effect Of Nadroparin, A Low-Molecular-Weight Heparin, On Clinical And Angiographic Restenosis After Coronary Balloon Angioplasty
  25. FAC regimen → CAF regimen
  26. FADH → Flavin
  27. FAH gene → Fumarylacetoacetate hydrolase
  28. FALS → Amyotrophic lateral sclerosis
  29. FAMIS → Fosinopril In Acute Myocardial Infarction Study
  30. FANCC gene → Fanconi anemia, complementation group C
  31. FANCG gene → FANCG
  32. FANTASTIC → Randomized Multicenter Comparison Of Conventional Anticoagulation Versus Antiplatelet Therapy In Unplanned And Elective Coronary Stenting
  33. FAO → Food and Agriculture Organization
  34. FAST → Femoral Artery Stenting Trial
  35. FAST-MAG → Field Administration Of Stroke Therapy - Magnesium
  36. FASTER → Fibrinolytic And Aggrastat St Elevation Resolution First Abarelix Depot Study For Treating Endometriosis RapidlyFirst And Second Trimester Evaluation Of Risk
  37. FAS ligand → Fas ligand
  38. FATS → Familial Atherosclerosis Treatment Study (FATS)
  39. FATS Trial → Familial Atherosclerosis Treatment Study (FATS)
  40. FATS trial → Familial Atherosclerosis Treatment Study (FATS)
  41. FAVA → Provisionally unclassified vascular anomalies#Fibro adipose vascular anomaly (FAVA)
  42. FBG → Blood sugar
  43. FBS → Blood sugar
  44. FCM-R regimen → FMC-R regimen
  45. FCMR Regimen → FMC-R regimen
  46. FCM regimen → FMC regimen
  47. FD&C → Federal Food, Drug, and Cosmetic Act
  48. FDA → Food and Drug Administration
  49. FDA Advisors Under Review for the Potential of Financial Conflict. August 8, 2007 → Special:Badtitle/NS100:FDA Advisors Under Review for the Potential of Financial Conflict
  50. FDA Panel Recommends Approval of New DES → Special:Badtitle/NS100:FDA Panel Recommends Approval of New DES

View ( | ) (20 | 50 | 100 | 250 | 500)

Retrieved from "https://www.wikidoc.org/index.php/Special:ListRedirects"